Civil Plaintiff
New Jersey Will Receive $641 Million From a Nationwide Opioid Settlement
New Jersey is on track to receive more than $641 million as part of a nationwide opioid settlement agreement with Johnson & Johnson and the country’s three largest pharmaceutical distributors.
Every one of New Jersey’s counties and municipalities that are eligible to join the $26 billion settlement have signed on, which is significant because it paves the way for the state to collect the maximum amount, acting Attorney General Andrew J. Bruck said Wednesday.
The agreement with New Jersey-based Johnson & Johnson and three pharmaceutical distributors — McKesson, Cardinal Health and AmerisourceBergen — would resolve claims involving their roles in the country’s opioid crisis.
